Cargando…
The Efficacy and Safety of the WATCHMAN Device in LAA Occlusion in Patients with Non-Valvular Atrial Fibrillation Contraindicated to Oral Anticoagulation: A Focused Review
The standard treatment for stroke risk patients with non-valvular atrial fibrillation (NVAF) is the use of oral anticoagulants (OACs). However, a substantial number of patients have relative or absolute contraindications to OACs due to concerns of major bleeding risk and other adverse effects while...
Autores principales: | Majule, David Nehemiah, Jing, Chang, Rutahoile, Willfredius Mugishagwe, Shonyela, Felix Samuel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Editorial Committee of Annals of Thoracic and Cardiovascular Surgery
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6300422/ https://www.ncbi.nlm.nih.gov/pubmed/29962388 http://dx.doi.org/10.5761/atcs.ra.18-00014 |
Ejemplares similares
-
Cost effectiveness of left atrial appendage closure with the Watchman device for atrial fibrillation patients with absolute contraindications to warfarin
por: Reddy, Vivek Y., et al.
Publicado: (2016) -
Novel stroke risk reduction in atrial fibrillation: left atrial appendage occlusion with a focus on the Watchman closure device
por: Alipour, Arash, et al.
Publicado: (2017) -
Cost-effectiveness analysis of left atrial appendage occlusion in patients with atrial fibrillation and contraindication to oral anticoagulation
por: Labori, Frida, et al.
Publicado: (2021) -
Newer Anticoagulants for Non-Valvular Atrial Fibrillation
por: Harburger, Joseph M., et al.
Publicado: (2012) -
Experience of left atrial appendage occlusion with the WATCHMAN device in Chinese patients
por: Zhai, Zhengqin, et al.
Publicado: (2019)